Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the pyrroloquinoline class. Its structure features a fused pyrrole and quinoline ring system with hydroxy and methyl substitutions. It is listed in chemical databases such as DrugBank (DB07468), PubChem (CID:24178119), and ChemSpider. The compound has been referenced as an experimental molecule but there are no publicly available data on its clinical use or mechanism of action in humans or animals. No approved therapeutic indications or pharmacological targets have been established for this substance as of June 2025[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one.